Eagle Pharmaceuticals, Inc. (EGRX) Financials

EGRX Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 404.8 million 152.8 million
2023-03-31 414.2 million 171.3 million
2022-12-31 406.2 million 172.6 million
2022-09-30 390.1 million 154.7 million

EGRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 -132000 4.2 million
2023-03-31 -33.6 million 4.6 million
2022-12-31 37.5 million 4.1 million
2022-09-30 -13.2 million 3.5 million

EGRX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-06-30 5.2 million
2023-03-31 5.8 million
2022-12-31 8.2 million
2022-09-30 -3.5 million

EGRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 15.4 million - 1.4 million
2023-03-31 21.9 million - 1.6 million
2022-12-31 55.3 million 56.2 million 5.3 million
2022-09-30 15.4 million - 3.4 million

EGRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 13.2 million
2023-03-31 13.2 million
2022-12-31 13.1 million
2022-09-30 13.2 million

EGRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 6000 9.8 million 23.3 million 4.4 million
2023-03-31 58000 9.3 million 24.3 million 3.7 million
2022-12-31 10000 7.2 million 20.8 million 3.4 million
2022-09-30 10000 9.3 million 21.8 million 1.7 million

EGRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 64.6 million 16.9 million
2023-03-31 66.3 million 17.3 million
2022-12-31 60.7 million 19.9 million
2022-09-30 65.9 million 23.7 million

EGRX

Price: $4.75

52 week price:
3.95
25.29

Payout Ratio Range:
-375.76%
701.75%

Earnings Per Share: 0.85 USD

P/E Ratio: 6.88

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 130600

Ebitda: 25.9 million

Market Capitalization: 63.4 million

Links: